Measuring hepatitis C viremia in clinical samples: Can we trust the assays?

Hepatology

Volumn 26, Issue 1, 1997, Pages 1-4

  Pawlotsky, Jean Michel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; HEPATITIS C; HEPATITIS C VIRUS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIREMIA; VIRUS DETECTION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0030976826     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260131     Document Type: Review

References (26)

1. Pawlotsky JM, Roudot-Thoraval F, Bastie A, Darthuy F, Rémiré J, Métreau JM, Zafrani ES, et al. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 1996;174:1-7.
2. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. HEPATOLOGY 1995;22:1050-1056.
3. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2: 121-132.
4. McHutchison JG, Sedghi-Vaziri A, Russell J, Schmid P, Conrad A. Is there an optimal time to measure quantitative HCV RNA to predict outcome following interferon treatment for chronic HCV infection [Abstract]. HEPATOLOGY 1996;24:356A.
5. Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 1995; 123:321-329.
6. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JYN, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
7. Duvoux C, Pawlotsky JM, Cherqui D, Tran Van Nhieu J, Métreau JM, Fagniez PL, Duval J, et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995;60:457-461.
8. Mayerat C, Bürgisser P, Lavanchy D, Mantegani A, Frei PC. Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation. J Clin Microbiol 1996;34:2702-2706.
9. Roth WK, Lee JH, Rüster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol 1996;34:261-264.
10. Olmedo E, Costa J, Lopez-Labrador FX, Forns X, Guilera M, Ampurdanes S, Sanchez-Tapias JM, et al. Comparison of two quantitative HCV RNA assays. Evolution of the viremia in a short term [Abstract]. HEPATOLOGY 1996;24:384A.
11. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA, Irvine BD, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995; 226:120-129.
12. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Hijioka T, Katayama K, Fusamoto H, et al. Comparison of HCV RNA levels by a branched DNA probe assay and an Amplicor HCV Monitor kit [Abstract]. HEPATOLOGY 1995;22:470A.
13. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, Urdea M, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched DNA technology. J Clin Microbiol 1996;34:901-907.
14. Gretch DR, dela Rosa C, Corey L, Carithers RL. Assessment of hepatitis C viremia using molecular amplification technologies. Viral Hep Rev 1996;2:85-96.
15. Jacob S, Baudy D, Jones E, Xu L, Mason A, Perrillo R. Second generation HCV bDNA testing vs quantitative RT-PCR (Monitor) in chronic hepatitis C (CHC) [Abstract]. HEPATOLOGY 1996;24:384A.
16. Reuben A, Barritt J, Conrad A. Falsely low hepatitis C virus (HCV) RNA results [Abstract]. HEPATOLOGY 1996;24:386A.
17. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339:237-238.
18. Izopet J, Payen JL, Zarski JP, Seigneurin JM, Dussaix E, Langlois C, Sayada C, et al. Quantification of hepatitis C virus RNA by RT-PCR: multicentre quality check [Abstract]. HEPATOLOGY 1996;24:385A.
19. Hadziyannis E, Fried MW, Nolte FS. Evaluation of two methods for quantitation of hepatitis C virus RNA. Mol Diagn 1997;2:39-46.
20. Yen-Lieberman B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS clinical trials group virology laboratories. J Clin Microbiol 1997;34: 2695-2701.
21. Schuurman R, Descamps D, Weverling GJ, Kaye S, Tijnagel J, Williams I, van Leeuwen R, et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3016-3022.
22. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and in-house limiting dilution method. J Clin Microbiol 1997; 35:187-192.
23. O'Brien CB, Henzel B, Wolfe L, Yoder A. HCV RNA quantitation: is plasma equivalent to serum [Abstract]? HEPATOLOGY 1995;22:465A.
24. Lau JYN, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995;346:425-426.
25. Shiffman ML, Reddy KR, Hofmann CM, Roach K, Ferreira-Gonzalez A, De Medina M, Garrett C, et al. Comparison of Chiron bDNA assay to Roche Amplicor quantitative PCR and Knodell score in the assessment of patients with chronic hepatitis C virus (HCV) [Abstract]. HEPATOLOGY 1996;24:385A.
26. Oshita M, Kasahara A, Hagiwara H, Katayama K, Sasaki Y, Hayashi N. Evaluation of three quantitative assays for HCV: prediction of efficacy of interferon therapy [Abstract]. HEPATOLOGY 1996;24:385A.